We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
EMA approved CASGEVY for children 5-11 years with sickle cell anemia. 100% efficacy, price 1.8 million EUR. Risks and benefits — in the analysis. Learn more.
